These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6487192)

  • 21. Studies on Pasteurella multocida. VI. Nature of systemic immunity and analysis of the correlation between levels of immunity induced by various fowl cholera vaccines and protection against challenge.
    Dua SK; Maheswaran SK
    Avian Dis; 1978; 22(4):748-64. PubMed ID: 749893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium.
    Glisson JR; Contreras MD; Cheng IH; Wang C
    Avian Dis; 1993; 37(4):1074-9. PubMed ID: 8141736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Pasteurella multocida mutants of low virulence. II. Immunologic response of turkeys.
    Hofacre CL; Glisson JR; Kleven SH
    Avian Dis; 1989; 33(2):275-8. PubMed ID: 2751560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(4):975-85. PubMed ID: 1485881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eradication of pasteurellosis from aquatic birds on farms].
    Muryĭ AA; Bibikov FA; Sazhnev VN; Dubrov IS
    Veterinariia; 1979 Jul; (7):41-2. PubMed ID: 161675
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo.
    Rimler RB
    Avian Dis; 2001; 45(3):572-80. PubMed ID: 11569729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-protection factor(s) of Pasteurella multocida: passive immunization of turkeys against fowl cholera caused by different serotypes.
    Rimler RB
    Avian Dis; 1987; 31(4):884-7. PubMed ID: 3442539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
    Wang C; Glisson JR
    Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic types and physiologic characteristics of 46 avian Pasteurella anatipestifer cultures.
    Brogden KA; Rhoades KR; Rimler RB
    Avian Dis; 1982; 26(4):891-6. PubMed ID: 6818940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoprophylaxis against an acute P. multocida type D infection in Cairina moschata].
    Schimmel D
    Berl Munch Tierarztl Wochenschr; 1990 Nov; 103(11):384-5. PubMed ID: 2268254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on Pasteurella multocida of birds. Fourth communication: A new polyvalent oil-adjuvant vaccine.
    Farid AH; Torky HA; el-Nimr MM; Akeula M; Ezzat M
    Arch Exp Veterinarmed; 1987 Mar; 41(2):208-11. PubMed ID: 3606316
    [No Abstract]   [Full Text] [Related]  

  • 33. Exposing turkeys by various routes to an avirulent and virulent strains of Pasteurella multocida.
    Bierer BW; Deriuex WT
    Poult Sci; 1973 Nov; 52(6):2290-8. PubMed ID: 4788999
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of the route of infection of Pasteurella anatipestifer on the clinical and immune responses of white Pekin ducks.
    Hatfield RM; Morris BA
    Res Vet Sci; 1988 Mar; 44(2):208-14. PubMed ID: 3387674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a subcutaneously administered, ultraviolet light-killed Pasteurella haemolytica A1-containing vaccine against transthoracic challenge exposure in goats.
    Purdy CW; Straus DC; Sutherland RJ; Ayres JR
    Am J Vet Res; 1996 Aug; 57(8):1168-74. PubMed ID: 8836369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens.
    Scott PC; Markham JF; Whithear KG
    Avian Dis; 1999; 43(1):83-8. PubMed ID: 10216763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an enzyme-linked immunosorbent assay to measure antibody responses in turkeys against Pasteurella multocida.
    Marshall MS; Robison RA; Jensen MM
    Avian Dis; 1981; 25(4):964-71. PubMed ID: 7039594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A growth medium for the production of a bacterin for immunization against infectious coryza.
    Rimler RB; Shotts EB; Davis RB
    Avian Dis; 1975; 19(2):318-22. PubMed ID: 1156259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of pathogenicity to the growth of Pasteurella multocida serotype 3,4 isolates in normal turkey plasma.
    Lee MD; Brown J; Wooley RE; Glisson JR
    Avian Dis; 1988; 32(3):509-12. PubMed ID: 3196266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fowl cholera bacterins: host-specific cross-immunity induced in turkeys with Pasteurella multocida propagated in embryonating turkey eggs.
    Heddleston KL; Rebers PA
    Avian Dis; 1974; 18(2):231-9. PubMed ID: 4133381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.